DaVita Aktie
WKN: 897914 / ISIN: US23918K1088
06.01.2017 23:15:00
|
Dialysis Community Seeks Emergency Relief to Block CMS' Unlawful "Midnight" Rule Harming Patients
DENVER, Jan. 6, 2017 /PRNewswire/ -- Today, a group representing dialysis patients and providers filed suit seeking an emergency temporary restraining order in the United States District Court for the Eastern District of Texas, Sherman Division against the Centers for Medicare and Medicaid Services' (CMS) Interim Final Rule, which was issued in violation of federal law, according to the suit, and threatens to cause significant and irreparable harm to dialysis patients.
The "midnight" rule was issued on December 14th bypassing the normal notice and comment period and is set to take effect days before the change in presidential administrations. If permitted to take effect, this rule will cause immediate harm to dialysis patients, some of the most vulnerable patients in the United States, by causing great disruption in their care, exposing them to additional costs and potentially denying them access to health insurance. The plaintiff group seeks an injunction to at least defer the effective date of the rule so as to allow proper time for notice and comment.
"We felt we had no choice but to challenge this hastily implemented rule to protect the interests of our patients and those of the greater kidney care community," said Philipp Stephanus, senior vice president in charge of patient support functions at DaVita.
Additionally, DaVita announced it had received a subpoena from the United States Attorney for the District of Massachusetts seeking the production of information related to charitable premium assistance. The company looks forward to working with the government to allow for clarity on these complex issues.
About DaVita Inc. (NYSE:DVA)
DaVita Inc., a Fortune 500® company, is the parent company of DaVita Kidney Care and HealthCare Partners, a DaVita Medical Group. DaVita Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of Sept. 30, 2016, DaVita Kidney Care operated or provided administrative services at 2,318 outpatient dialysis centers located in the United States serving approximately 186,000 patients. The company also operated 139 outpatient dialysis centers located in 11 countries outside the United States. HealthCare Partners manages and operates medical groups and affiliated physician networks in California, Nevada, New Mexico, Florida, Colorado and Washington in its pursuit to deliver excellent-quality health care in a dignified and compassionate manner. As of Sept. 30, 2016, HealthCare Partners provided integrated care management for approximately 750,000 patients. For more information, please visit www.davita.com.
DaVita is a registered trademark of DaVita Inc.
Contact Information
Media:
Skip Thurman
(303) 876-6610
skip.thurman@davita.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dialysis-community-seeks-emergency-relief-to-block-cms-unlawful-midnight-rule-harming-patients-300387240.html
SOURCE DaVita Inc.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DaVita Inc Registered Shsmehr Nachrichten
21.04.25 |
S&P 500-Wert DaVita-Aktie: So viel Gewinn hätte ein Investment in DaVita von vor 10 Jahren eingebracht (finanzen.at) | |
14.04.25 |
Börse New York: S&P 500 letztendlich in Grün (finanzen.at) | |
14.04.25 |
Starker Wochentag in New York: S&P 500 notiert am Nachmittag im Plus (finanzen.at) | |
14.04.25 |
NYSE-Handel: S&P 500 mittags stärker (finanzen.at) | |
14.04.25 |
S&P 500-Papier DaVita-Aktie: So viel Gewinn hätte ein Investment in DaVita von vor 5 Jahren eingefahren (finanzen.at) | |
14.04.25 |
Starker Wochentag in New York: S&P 500 zeigt sich zum Handelsstart fester (finanzen.at) | |
07.04.25 |
S&P 500-Papier DaVita-Aktie: So viel hätte eine Investition in DaVita von vor 3 Jahren abgeworfen (finanzen.at) | |
31.03.25 |
S&P 500-Papier DaVita-Aktie: So viel Gewinn hätte ein DaVita-Investment von vor einem Jahr eingefahren (finanzen.at) |
Analysen zu DaVita Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
DaVita Inc Registered Shs | 123,15 | 0,49% |
|